Company

Linkster Therapeutics

Biotechnology Research Zurich, Zürich, Ch 5 employees

Employees: 5
Contacts: 2
Emails: 2

linkstertx.com LinkedIn

Linkster Therapeutics Overview

Headquarters: Zurich, Zürich, Ch
Website: linkstertx.com
Industry: Biotechnology Research
Employees: 5
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Antibody precision medicines engineered In Vivo High-throughput pharmacokinetics & biodistribution Novel Sybody/Nanobody platform technology

About Linkster Therapeutics

Linkster is a swiss-based precision medicine company focusing on multi-specific antibodies and tissue-specific delivery. The company creates next generation targeted therapeutics through its Flycode® platform for high-throughput cellular and in vivo antibody engineering. Linkster has entered into several agreements with pharmaceutical and biotech companies and is actively seeking further partnerships for the co-development of innovative therapeutic products. For more information, please visit https://linkstertx.com

Linkster Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Linkster Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Iwan Zimmermann	Co-founder & Chief Scientific Officer	Zurich, Switzerland	Email
Roger Dawson	CEO & Co-founder at Linkster	Zurich, Switzerland	Email
Cedric Hutter	Scientist at Linkster Therapeutics	Zürich Metropolitan Area, Switzerland	View